Stocks and Investing Stocks and Investing
Mon, February 22, 2021

Tejas Savant Maintained (TXG) at Buy with Increased Target to $215 on, Feb 22nd, 2021


Published on 2024-10-27 15:42:45 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $145 to $215 on, Feb 22nd, 2021.

Tejas has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 1 agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


These are the ratings of the 3 analyists that currently disagree with Tejas


  • Doug Schenkel of "Cowen & Co." Maintained at Buy with Increased Target to $200 on, Thursday, February 18th, 2021
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $240 on, Thursday, February 18th, 2021
  • Tycho Peterson of "JP Morgan" Maintained at Buy with Increased Target to $195 on, Thursday, February 18th, 2021
Contributing Sources